Panniculitis induced by interferon beta vascular toxicity;Panniculites secondaires à la toxicité vasculaire de l'interféron béta-1a

Annales de Dermatologie et de Venereologie

Volumn 134, Issue 4, 2007, Pages 374-377

  Soria, A ^a   Maubec, E ^a   Henry Feugeas, M C ^a   Marinho, E ^a   Le Bozec, P ^b,c   Huisse, M G ^a   Pocidalo, M A ^a   Descamps, V ^a   Crickx, B ^a  

^a BICHAT HOSPITAL   (France)

^b BEAUJON HOSPITAL   (France)

^c ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; BETA INTERFERON; BETA1A INTERFERON;

ADULT; ARTICLE; AVASCULAR NECROSIS; CASE REPORT; DRUG WITHDRAWAL; FEMALE; FEVER; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOTHERAPY; INJECTION SITE PAIN; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PANNICULITIS; SKIN BIOPSY; SKIN EDEMA; THROMBOSIS; VASCULITIS;

EID: 34248390058     PISSN: 01519638     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0151-9638(07)89194-0     Document Type: Article

References (10)

1. Rieckmann P, Toyka KV, Bassetti C, Beer K, Beer S, Buettner U, et al. Multiple Sclerosis Therapy Consensus Group. Escalating immunotherapy of multiple sclerosis-new aspects and practical application. J Neurol 2004;251:1329-39.
2. Bayas A, Gold R. Lessons from 10 years of interferon beta-1b (Betaferon/Betaseron) treatment. J Neurol 2003;250(Suppl 4):IV3-8.
3. Conférence de consensus, érysipèle, fasciite nécrosante. Med Mal Inf 2000;30:241-5.
4. Panse I, Bourrat E, Remy P, Vignon-Pennaman MD, Lebbe C, Morel P, et al. Panniculite cytophagique et sclérosante après injection souscutanée de Betaféron® : un effet secondaire local de l'interféron beta. Ann Dermatol Venereol 2003;130(Suppl 4):4S226(abstract).
5. Heinzerling L, Dummer R, Burg G, Schmid-Grendelmeier P. Panniculitis after subcutaneous injection of interferon beta in a multiple sclerosis patient. Eur J Dermatol 2002;12:194-7.
6. Cooper CL, Gerstein R, Kaita K. Fasciitis complicating subcutaneous injection of interferon beta. Can J Gastroenterol 2000;14(Suppl B):81B-82B.
7. Elgart GW, Sheremata W, Ahn YS. Cutaneous reactions to recombinant human interferon beta-1b: the clinical and histologic spectrum. J Am Acad Dermatol 1997;37:553-8.
8. Christian MM, Diven DG, Sanchez RL, Soloway RD. Injection site vasculitis in a patient receiving interferon alfa for chronic hepatitis C. J Am Acad Dermatol 1997;37:118-20.
9. Radziwill AJ, Courvoisier S. Severe necrotising cutaneous lesions complicating treatment with interferon beta-1a. J Neurol Neurosurg Psychiatry 1999;67:115.
10. Ferroni P, Roselli M, Diodati A, Casciani CU, Gazzaniga PP. Effects on platelet function by human interferon-beta in carcinoma patients. Anticancer Res 1994;14:2779-84.